Evidence map›Paper›PMID 40463339›Full record

ArticleRSC advances2025

Design, synthesis and cytotoxic research of a novel antitumor model based on acrylamide-PABA analogs

Maha Ali Alghamdi, Mustafa R Abdulbaqi, Dalal Sulaiman Alshaya, Jawaher Alharthi, Hanadi A Katouah, Fahmy Gad Elsaid, Eman Fayad, Ali H Abu Almaaty, Abdullah Yahya Abdullah Alzahrani, Botros Y Beshay

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maha Ali AlghamdiDepartment of Biotechnology, College of Sciences, Taif University P.O. Box 11099 Taif 21944 Saudi Arabia.ORCID https://orcid.org/0000-0002-5424-388X
Mustafa R AbdulbaqiDepartment of Pharmaceutics, College of Pharmacy, Al-Naji University Baghdad 10015 Iraq.
Dalal Sulaiman AlshayaDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University P.O. Box 84428 Riyadh 11671 Saudi Arabia.ORCID https://orcid.org/0000-0002-0682-8189
Jawaher AlharthiDepartment of Biotechnology, College of Sciences, Taif University P.O. Box 11099 Taif 21944 Saudi Arabia.ORCID https://orcid.org/0000-0003-4017-2926
Hanadi A KatouahChemistry Department, College of Science, Umm Al-Qura University 21955 Makkah Saudi Arabia.ORCID https://orcid.org/0000-0001-9044-2491
Fahmy Gad ElsaidDepartment of Biology, College of Science, King Khalid University PO Box 960 Asir Abha 61421 Saudi Arabia.ORCID https://orcid.org/0000-0002-7754-2524
Eman FayadDepartment of Biotechnology, College of Sciences, Taif University P.O. Box 11099 Taif 21944 Saudi Arabia.ORCID https://orcid.org/0000-0003-2916-0254
Ali H Abu AlmaatyDepartment of Zoology, Faculty of Science, Port Said University Port Said Egypt aliabuelmaaty8@gmail.com.ORCID https://orcid.org/0009-0002-6225-4308
Abdullah Yahya Abdullah AlzahraniDepartment of Chemistry, Faculty of Science, King Khalid University Abha 61413 Saudi Arabia.
Botros Y BeshayPharmaceutical Sciences (Pharmaceutical Chemistry) Department, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport Alexandria P.O. Box 1029 Egypt.ORCID https://orcid.org/0000-0002-9153-8468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the human health is facing numerous challenges, especially with regard to cancer. Therefore, new treatment options that specifically target tumor cells will inevitably improve the therapeutic toolkit for various cancers. In this regard, a sequence of acrylamide-PABA hybrids 4a-j was synthesized, and their formation was confirmed

Identifiers

PMID40463339
PMCPMC12131314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.